thank stand welcome company earn conference call time participant listen mode speaker presentation question answer session operator instruction please advise today conference record operator instruction would like hand conference speaker today vice president investor relation risk management please ahead vice president investor relation risk management good afternoon welcome company fourth quarter full year earn conference call today call result guidance include earn release remain time question presenter today call white president chief executive officer chief financial officer treasurer begin would like remind conference call contain forward look statement include revenue earn share guidance statement regard anticipate result operation market regulatory condition acquisition integration acquisition anticipate benefit forward look statement depend assumption data method incorrect imprecise subject risk uncertainty event could cause actual result future action company differ materially describe forward look statement forth caption forward look statement today earn release describe file include form form file available website cooperco additional question follow call please call investor line email cooperco turn call open remark white president chief executive officer thank welcome everyone company fiscal fourth quarter conference call please report another strong quarter lead record revenue exceed high expectation quarter daily silicone hydrogel myopia management portfolio post strong result account strategy generate share gain market around world within fertility business continue perform extremely recently announce excite agreement acquire generate life science great strategic fertility labor delivery offer full fiscal year proud report record revenue record earn record free cash flow enter fiscal strong momentum expect another record year regard fourth quarter result report percentage constant currency basis consolidate revenue million million million earn share daily silicone hydrogel portfolio lead grow three region report strength product category premium product mass market product clariti perform really also solid quarter support strength toric multifocal region grow lead daily silicone hydrogel lens particular strength continue strong activity grow healthy improve consumer activity strength account drive growth share gain within region post broad base growth daily silicone grow lead steady improvement consumer activity success several product launch region remain important growth driver invest accordingly outperform market take share portfolio post solid result drive growth market around world broad offer include toric multifocal energy innovative product monthly space regard product launch remain incredibly active highlight past many product range extension launch around world clarity activity continue drive consistent share gain expect continue recent launch want highlight quarter multifocal launch product several major market feedback result absolutely fantastic consistently hear care practitioner binocular progressive system breakthrough approach simplify provide optimal visual acuity level hear patient best multifocal ever wear exceptional near intermediate distant vision expect launch continue perform extremely provide nice halo effect support already successful brand torics sphere move myopia management portfolio grow million million ortho product reach goal million year year year momentum strong global leader myopia management space portfolio broadest industry comprise approve myopia control product broad range market lead ortho lens innovative vision glass regard quite reach target quarter reach million sale full year impressive year year make great progress independent group retailer around world momentum channel also make great progress sign exclusive distribution agreement actively promote follow soft launch last month largest ophthalmic trade show target full launch fiscal also assemble advisory board opinion leader whose affiliate hospital represent myopia management contact lens volume expert provide fantastic insight position grow ortho even faster successfully reminder childhood myopia rate estimate reduce myopia priority government opportunity significant lastly recently present industry lead seven year clinical study confirm product work nearly myopic child myopia progression roughly average work child start treatment work long child wear rebound treatment stop driver continue support short long term growth regard myopia management product ortho portfolio perform really lead success commercially launch myopia management glass partner several additional launch come soon overall myopia management momentum strong still target constant currency growth fiscal roughly million sale conclude vision estimate overall contact lens market grow calendar grow even remain level recent data roughly care practitioner state capacity serve patient mostly staff challenge trend positive expect market grow range come year support improve activity reopen activity meanwhile long term macro growth trend remain solid roughly third world myopic today expect increase close fiscal year really strong note exceed high expectation enter fiscal robust product portfolio product launch grow myopia management business strong data ensure seize growth opportunity front increase sale force investment continue successful myopia management investment strategy strong momentum grow faster market expect continue move fertility business perform exceptionally grow year year million strength around world throughout product portfolio include consumables capital equipment genomics particular area continue strength witness platform proprietary automate management system clinic implement maximize safety security optimize practice system like especially important today world improve quality control workflow management enable social distance prevent mistake embryo mismatch unfortunately occasionally hear regard broader fertility industry addressable market approach billion long term growth expect estimate eight couple trouble pregnant variety factor increase maternal million individual worldwide suffer infertility give improve access treatment increase patient awareness greater comfort discuss increase global disposable income industry grow nicely many year come within office surgical unit grow medical device perform grow lead portfolio uterine several surgical device next generation advance product line meanwhile decline largely forecast activity last quarter price increase similar general market performance soft likely staff challenge lastly recently announce agreement acquire generate life science billion many know company cord blood storage business phenomenal expand year business great strategic leader donor service fertility treatment leader cord blood cord tissue storage excellent labor delivery group investor presentation website summarize deal provide additional color roughly third business fertility estimate grow long term support general industry growth meanwhile combine generate offer exist portfolio allow leverage infrastructure launch product international accelerate growth beyond range third business cord blood cord tissue storage expect grow long term drive increase demand cord tissue stem cell optimism around significant number clinical trial stem cell regenerative medicine consolidate business offer long term sustainable growth believe opportunity push range higher potential revenue synergy leverage expertise finish make comment fiscal introduce annual guidance today world challenge give uncertainty regardless organic revenue growth strong expect continue invest product launch intelligently leverage operation ensure receive strong return believe innovative company contact lens space today lead product myopia management broadest product offer market extremely excite position lead fertility business company remain steady upward trend continue fiscal many year beyond turn call chief financial officer treasurer thank good afternoon everyone commentary basis please refer earn release reconciliation result fourth quarter consolidate revenue increase year year also constant currency million consolidate gross margin decrease year year basis point drive primarily currency partially offset lower manufacture operate expense grow strategic investment sale market support myopia management fertility continue within slightly higher initially forecast investment vision along elevate distribution higher demand direct shipment consolidate operate margin last year interest expense million lower average debt effective rate help stock option exercise quarter roughly million average share outstanding negatively impact roughly worse expect give guidance last quarter free cash flow solid million comprise million operate cash flow offset million capex debt decrease billion adjust leverage ratio improve time move guidance exclude recently announce generate life science acquisition consolidate revenue expect range billion billion constant currency revenue billion billion constant currency revenue million million constant currency expect range constant currency rate expect around midpoint guidance equate constant currency revenue growth roughly constant currency growth roughly regard currency year year basis expect headwind roughly revenue impact detrimental expect range open call question touch generate life science acquisition announce today optimistic close next couple week would give roughly month operation fiscal still wait final regulatory approval provide specific guidance today meantime walk deal accretion expect previously announce generate roughly million trail month revenue gross margin expect roughly opex expect elevate year synergy expect minimal integrate invest business closer secure permanent finance transaction update year accretion estimate around would expect accretion improve year synergy summary please close fiscal year look forward look forward beyond continue believe strategic investment drive line momentum support share gain business long term sustainable earn growth hand back operator question